Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP285651.RATI5EcNLIvOEaHB3Y5YkntfUfg7jFD-J8ogXb0ltd42w130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP285651.RATI5EcNLIvOEaHB3Y5YkntfUfg7jFD-J8ogXb0ltd42w130_assertion type Assertion NP285651.RATI5EcNLIvOEaHB3Y5YkntfUfg7jFD-J8ogXb0ltd42w130_head.
- NP285651.RATI5EcNLIvOEaHB3Y5YkntfUfg7jFD-J8ogXb0ltd42w130_assertion description "[Secondary outcomes included progression to CDR at least 0�5, symptomatic Alzheimer's disease (score of at least 0�5 for memory and at least one other domain and cognitive impairments deemed to be due to Alzheimer's disease), and mortality.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP285651.RATI5EcNLIvOEaHB3Y5YkntfUfg7jFD-J8ogXb0ltd42w130_provenance.
- NP285651.RATI5EcNLIvOEaHB3Y5YkntfUfg7jFD-J8ogXb0ltd42w130_assertion evidence source_evidence_literature NP285651.RATI5EcNLIvOEaHB3Y5YkntfUfg7jFD-J8ogXb0ltd42w130_provenance.
- NP285651.RATI5EcNLIvOEaHB3Y5YkntfUfg7jFD-J8ogXb0ltd42w130_assertion SIO_000772 24012374 NP285651.RATI5EcNLIvOEaHB3Y5YkntfUfg7jFD-J8ogXb0ltd42w130_provenance.
- NP285651.RATI5EcNLIvOEaHB3Y5YkntfUfg7jFD-J8ogXb0ltd42w130_assertion wasDerivedFrom befree-20150227 NP285651.RATI5EcNLIvOEaHB3Y5YkntfUfg7jFD-J8ogXb0ltd42w130_provenance.
- NP285651.RATI5EcNLIvOEaHB3Y5YkntfUfg7jFD-J8ogXb0ltd42w130_assertion wasGeneratedBy ECO_0000203 NP285651.RATI5EcNLIvOEaHB3Y5YkntfUfg7jFD-J8ogXb0ltd42w130_provenance.